Rigel Pharmaceuticals RIGL Single reportable segment — Revenue recognized
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's single reportable segment — revenue recognized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's single reportable segment — revenue recognized?
- Rigel Pharmaceuticals (RIGL) reported single reportable segment — revenue recognized of $58.82M in Q1 2026.
- What does single reportable segment — revenue recognized mean?
- Represents the total revenue generated by the company's primary operating segment from contracts with customers. This includes product sales, licensing fees, and milestone payments, reflecting the core commercial success of the firm's drug portfolio.